[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drug Eluting Beads Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

June 2024 | 108 pages | ID: GE3A6B94906EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Drug Eluting Beads market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic option in unresectable tumours. Drug eluting beads are widely used in primary and liver dominant metastatic disease of the liver. Drug eluting beads improves the safety and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). The drug eluting bead is given through the catheter directly to the liver tumor. Giving chemotherapy with the bead is more beneficial, as the chemotherapy is gradually released from the beads. Slowly released chemotherapy from the bead destroys the tumor over a greater period of time. Drug eluting beads are new embolic agents that allows the continuous release of chemotherapeutic agents.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Drug Eluting Beads industry chain, the market status of Hospitals (Oncozene Beads, Quadra Sphere), Specialized Clinics (Oncozene Beads, Quadra Sphere), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Eluting Beads.

Regionally, the report analyzes the Drug Eluting Beads markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Eluting Beads market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Drug Eluting Beads market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Eluting Beads industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Oncozene Beads, Quadra Sphere).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Eluting Beads market.

Regional Analysis: The report involves examining the Drug Eluting Beads market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Eluting Beads market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Drug Eluting Beads:

Company Analysis: Report covers individual Drug Eluting Beads manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Eluting Beads This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialized Clinics).

Technology Analysis: Report covers specific technologies relevant to Drug Eluting Beads. It assesses the current state, advancements, and potential future developments in Drug Eluting Beads areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Eluting Beads market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Drug Eluting Beads market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • Oncozene Beads
  • Quadra Sphere
  • LC Beads
  • Others
Market segment by Application
  • Hospitals
  • Specialized Clinics
  • Research Centers
  • Ambulatory Surgical Centers
Major players covered
  • Biocompatibles
  • BTG International
  • Merit Medical Systems
  • CeloNova BioSciences
  • ABK Biomedical
  • Boston Scientific
  • Medtronic
  • Merit Medical Systems
  • Surefire Medical
  • Terumo
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Drug Eluting Beads product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Drug Eluting Beads, with price, sales, revenue and global market share of Drug Eluting Beads from 2019 to 2024.

Chapter 3, the Drug Eluting Beads competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Drug Eluting Beads breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Drug Eluting Beads market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Beads.

Chapter 14 and 15, to describe Drug Eluting Beads sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Drug Eluting Beads
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Drug Eluting Beads Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 Oncozene Beads
  1.3.3 Quadra Sphere
  1.3.4 LC Beads
  1.3.5 Others
1.4 Market Analysis by Application
  1.4.1 Overview: Global Drug Eluting Beads Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Hospitals
  1.4.3 Specialized Clinics
  1.4.4 Research Centers
  1.4.5 Ambulatory Surgical Centers
1.5 Global Drug Eluting Beads Market Size & Forecast
  1.5.1 Global Drug Eluting Beads Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Drug Eluting Beads Sales Quantity (2019-2030)
  1.5.3 Global Drug Eluting Beads Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 Biocompatibles
  2.1.1 Biocompatibles Details
  2.1.2 Biocompatibles Major Business
  2.1.3 Biocompatibles Drug Eluting Beads Product and Services
  2.1.4 Biocompatibles Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 Biocompatibles Recent Developments/Updates
2.2 BTG International
  2.2.1 BTG International Details
  2.2.2 BTG International Major Business
  2.2.3 BTG International Drug Eluting Beads Product and Services
  2.2.4 BTG International Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 BTG International Recent Developments/Updates
2.3 Merit Medical Systems
  2.3.1 Merit Medical Systems Details
  2.3.2 Merit Medical Systems Major Business
  2.3.3 Merit Medical Systems Drug Eluting Beads Product and Services
  2.3.4 Merit Medical Systems Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Merit Medical Systems Recent Developments/Updates
2.4 CeloNova BioSciences
  2.4.1 CeloNova BioSciences Details
  2.4.2 CeloNova BioSciences Major Business
  2.4.3 CeloNova BioSciences Drug Eluting Beads Product and Services
  2.4.4 CeloNova BioSciences Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 CeloNova BioSciences Recent Developments/Updates
2.5 ABK Biomedical
  2.5.1 ABK Biomedical Details
  2.5.2 ABK Biomedical Major Business
  2.5.3 ABK Biomedical Drug Eluting Beads Product and Services
  2.5.4 ABK Biomedical Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 ABK Biomedical Recent Developments/Updates
2.6 Boston Scientific
  2.6.1 Boston Scientific Details
  2.6.2 Boston Scientific Major Business
  2.6.3 Boston Scientific Drug Eluting Beads Product and Services
  2.6.4 Boston Scientific Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 Boston Scientific Recent Developments/Updates
2.7 Medtronic
  2.7.1 Medtronic Details
  2.7.2 Medtronic Major Business
  2.7.3 Medtronic Drug Eluting Beads Product and Services
  2.7.4 Medtronic Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Medtronic Recent Developments/Updates
2.8 Merit Medical Systems
  2.8.1 Merit Medical Systems Details
  2.8.2 Merit Medical Systems Major Business
  2.8.3 Merit Medical Systems Drug Eluting Beads Product and Services
  2.8.4 Merit Medical Systems Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 Merit Medical Systems Recent Developments/Updates
2.9 Surefire Medical
  2.9.1 Surefire Medical Details
  2.9.2 Surefire Medical Major Business
  2.9.3 Surefire Medical Drug Eluting Beads Product and Services
  2.9.4 Surefire Medical Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.9.5 Surefire Medical Recent Developments/Updates
2.10 Terumo
  2.10.1 Terumo Details
  2.10.2 Terumo Major Business
  2.10.3 Terumo Drug Eluting Beads Product and Services
  2.10.4 Terumo Drug Eluting Beads Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.10.5 Terumo Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: DRUG ELUTING BEADS BY MANUFACTURER

3.1 Global Drug Eluting Beads Sales Quantity by Manufacturer (2019-2024)
3.2 Global Drug Eluting Beads Revenue by Manufacturer (2019-2024)
3.3 Global Drug Eluting Beads Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Drug Eluting Beads by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Drug Eluting Beads Manufacturer Market Share in 2023
  3.4.2 Top 6 Drug Eluting Beads Manufacturer Market Share in 2023
3.5 Drug Eluting Beads Market: Overall Company Footprint Analysis
  3.5.1 Drug Eluting Beads Market: Region Footprint
  3.5.2 Drug Eluting Beads Market: Company Product Type Footprint
  3.5.3 Drug Eluting Beads Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Drug Eluting Beads Market Size by Region
  4.1.1 Global Drug Eluting Beads Sales Quantity by Region (2019-2030)
  4.1.2 Global Drug Eluting Beads Consumption Value by Region (2019-2030)
  4.1.3 Global Drug Eluting Beads Average Price by Region (2019-2030)
4.2 North America Drug Eluting Beads Consumption Value (2019-2030)
4.3 Europe Drug Eluting Beads Consumption Value (2019-2030)
4.4 Asia-Pacific Drug Eluting Beads Consumption Value (2019-2030)
4.5 South America Drug Eluting Beads Consumption Value (2019-2030)
4.6 Middle East and Africa Drug Eluting Beads Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Drug Eluting Beads Sales Quantity by Type (2019-2030)
5.2 Global Drug Eluting Beads Consumption Value by Type (2019-2030)
5.3 Global Drug Eluting Beads Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Drug Eluting Beads Sales Quantity by Application (2019-2030)
6.2 Global Drug Eluting Beads Consumption Value by Application (2019-2030)
6.3 Global Drug Eluting Beads Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Drug Eluting Beads Sales Quantity by Type (2019-2030)
7.2 North America Drug Eluting Beads Sales Quantity by Application (2019-2030)
7.3 North America Drug Eluting Beads Market Size by Country
  7.3.1 North America Drug Eluting Beads Sales Quantity by Country (2019-2030)
  7.3.2 North America Drug Eluting Beads Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Drug Eluting Beads Sales Quantity by Type (2019-2030)
8.2 Europe Drug Eluting Beads Sales Quantity by Application (2019-2030)
8.3 Europe Drug Eluting Beads Market Size by Country
  8.3.1 Europe Drug Eluting Beads Sales Quantity by Country (2019-2030)
  8.3.2 Europe Drug Eluting Beads Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Drug Eluting Beads Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Drug Eluting Beads Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Drug Eluting Beads Market Size by Region
  9.3.1 Asia-Pacific Drug Eluting Beads Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Drug Eluting Beads Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Drug Eluting Beads Sales Quantity by Type (2019-2030)
10.2 South America Drug Eluting Beads Sales Quantity by Application (2019-2030)
10.3 South America Drug Eluting Beads Market Size by Country
  10.3.1 South America Drug Eluting Beads Sales Quantity by Country (2019-2030)
  10.3.2 South America Drug Eluting Beads Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Drug Eluting Beads Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Drug Eluting Beads Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Drug Eluting Beads Market Size by Country
  11.3.1 Middle East & Africa Drug Eluting Beads Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Drug Eluting Beads Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Drug Eluting Beads Market Drivers
12.2 Drug Eluting Beads Market Restraints
12.3 Drug Eluting Beads Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Drug Eluting Beads and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drug Eluting Beads
13.3 Drug Eluting Beads Production Process
13.4 Drug Eluting Beads Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Drug Eluting Beads Typical Distributors
14.3 Drug Eluting Beads Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Drug Eluting Beads Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drug Eluting Beads Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Biocompatibles Basic Information, Manufacturing Base and Competitors
Table 4. Biocompatibles Major Business
Table 5. Biocompatibles Drug Eluting Beads Product and Services
Table 6. Biocompatibles Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Biocompatibles Recent Developments/Updates
Table 8. BTG International Basic Information, Manufacturing Base and Competitors
Table 9. BTG International Major Business
Table 10. BTG International Drug Eluting Beads Product and Services
Table 11. BTG International Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. BTG International Recent Developments/Updates
Table 13. Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table 14. Merit Medical Systems Major Business
Table 15. Merit Medical Systems Drug Eluting Beads Product and Services
Table 16. Merit Medical Systems Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merit Medical Systems Recent Developments/Updates
Table 18. CeloNova BioSciences Basic Information, Manufacturing Base and Competitors
Table 19. CeloNova BioSciences Major Business
Table 20. CeloNova BioSciences Drug Eluting Beads Product and Services
Table 21. CeloNova BioSciences Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. CeloNova BioSciences Recent Developments/Updates
Table 23. ABK Biomedical Basic Information, Manufacturing Base and Competitors
Table 24. ABK Biomedical Major Business
Table 25. ABK Biomedical Drug Eluting Beads Product and Services
Table 26. ABK Biomedical Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. ABK Biomedical Recent Developments/Updates
Table 28. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 29. Boston Scientific Major Business
Table 30. Boston Scientific Drug Eluting Beads Product and Services
Table 31. Boston Scientific Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Boston Scientific Recent Developments/Updates
Table 33. Medtronic Basic Information, Manufacturing Base and Competitors
Table 34. Medtronic Major Business
Table 35. Medtronic Drug Eluting Beads Product and Services
Table 36. Medtronic Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Medtronic Recent Developments/Updates
Table 38. Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table 39. Merit Medical Systems Major Business
Table 40. Merit Medical Systems Drug Eluting Beads Product and Services
Table 41. Merit Medical Systems Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Merit Medical Systems Recent Developments/Updates
Table 43. Surefire Medical Basic Information, Manufacturing Base and Competitors
Table 44. Surefire Medical Major Business
Table 45. Surefire Medical Drug Eluting Beads Product and Services
Table 46. Surefire Medical Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Surefire Medical Recent Developments/Updates
Table 48. Terumo Basic Information, Manufacturing Base and Competitors
Table 49. Terumo Major Business
Table 50. Terumo Drug Eluting Beads Product and Services
Table 51. Terumo Drug Eluting Beads Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Terumo Recent Developments/Updates
Table 53. Global Drug Eluting Beads Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Drug Eluting Beads Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Drug Eluting Beads Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Drug Eluting Beads, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Drug Eluting Beads Production Site of Key Manufacturer
Table 58. Drug Eluting Beads Market: Company Product Type Footprint
Table 59. Drug Eluting Beads Market: Company Product Application Footprint
Table 60. Drug Eluting Beads New Market Entrants and Barriers to Market Entry
Table 61. Drug Eluting Beads Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Drug Eluting Beads Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Drug Eluting Beads Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Drug Eluting Beads Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Drug Eluting Beads Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Drug Eluting Beads Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Drug Eluting Beads Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Drug Eluting Beads Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Drug Eluting Beads Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Drug Eluting Beads Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Drug Eluting Beads Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Drug Eluting Beads Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Drug Eluting Beads Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Drug Eluting Beads Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Drug Eluting Beads Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Drug Eluting Beads Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Drug Eluting Beads Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Drug Eluting Beads Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Drug Eluting Beads Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Drug Eluting Beads Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Drug Eluting Beads Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Drug Eluting Beads Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Drug Eluting Beads Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Drug Eluting Beads Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Drug Eluting Beads Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Drug Eluting Beads Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Drug Eluting Beads Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Drug Eluting Beads Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Drug Eluting Beads Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Drug Eluting Beads Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Drug Eluting Beads Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Drug Eluting Beads Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Drug Eluting Beads Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Drug Eluting Beads Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Drug Eluting Beads Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Drug Eluting Beads Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Drug Eluting Beads Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Drug Eluting Beads Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Drug Eluting Beads Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Drug Eluting Beads Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Drug Eluting Beads Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Drug Eluting Beads Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Drug Eluting Beads Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Drug Eluting Beads Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Drug Eluting Beads Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Drug Eluting Beads Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Drug Eluting Beads Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Drug Eluting Beads Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Drug Eluting Beads Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Drug Eluting Beads Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Drug Eluting Beads Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Drug Eluting Beads Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Drug Eluting Beads Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Drug Eluting Beads Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Drug Eluting Beads Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Drug Eluting Beads Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Drug Eluting Beads Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Drug Eluting Beads Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Drug Eluting Beads Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Drug Eluting Beads Raw Material
Table 121. Key Manufacturers of Drug Eluting Beads Raw Materials
Table 122. Drug Eluting Beads Typical Distributors
Table 123. Drug Eluting Beads Typical Customers

LIST OF FIGURES

Figure 1. Drug Eluting Beads Picture
Figure 2. Global Drug Eluting Beads Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drug Eluting Beads Consumption Value Market Share by Type in 2023
Figure 4. Oncozene Beads Examples
Figure 5. Quadra Sphere Examples
Figure 6. LC Beads Examples
Figure 7. Others Examples
Figure 8. Global Drug Eluting Beads Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Drug Eluting Beads Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Examples
Figure 11. Specialized Clinics Examples
Figure 12. Research Centers Examples
Figure 13. Ambulatory Surgical Centers Examples
Figure 14. Global Drug Eluting Beads Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Drug Eluting Beads Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Drug Eluting Beads Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Drug Eluting Beads Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Drug Eluting Beads Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Drug Eluting Beads Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Drug Eluting Beads by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Drug Eluting Beads Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Drug Eluting Beads Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Drug Eluting Beads Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Drug Eluting Beads Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Drug Eluting Beads Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Drug Eluting Beads Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Drug Eluting Beads Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Drug Eluting Beads Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Drug Eluting Beads Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Drug Eluting Beads Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Drug Eluting Beads Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Drug Eluting Beads Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Drug Eluting Beads Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Drug Eluting Beads Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Drug Eluting Beads Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Drug Eluting Beads Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Drug Eluting Beads Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Drug Eluting Beads Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Drug Eluting Beads Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Drug Eluting Beads Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Drug Eluting Beads Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Drug Eluting Beads Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Drug Eluting Beads Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Drug Eluting Beads Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Drug Eluting Beads Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Drug Eluting Beads Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Drug Eluting Beads Consumption Value Market Share by Region (2019-2030)
Figure 56. China Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Drug Eluting Beads Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Drug Eluting Beads Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Drug Eluting Beads Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Drug Eluting Beads Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Drug Eluting Beads Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Drug Eluting Beads Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Drug Eluting Beads Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Drug Eluting Beads Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Drug Eluting Beads Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Drug Eluting Beads Market Drivers
Figure 77. Drug Eluting Beads Market Restraints
Figure 78. Drug Eluting Beads Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Drug Eluting Beads in 2023
Figure 81. Manufacturing Process Analysis of Drug Eluting Beads
Figure 82. Drug Eluting Beads Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source


More Publications